The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Desferal 500mg Vials Powder for Solution for Injection or Powder for Concentrate for Solution for Infusion



Novartis Ireland LimitedPA0896/008/001

Main Information

Trade NameDesferal 500mg Vials Powder for Solution for Injection or Powder for Concentrate for Solution for Infusion
Active SubstancesDeferoxamine mesilate
Dosage FormPowder for solution for injection/infusion
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/008/001

Group Information

ATC CodeV03AC Iron chelating agents
V03AC01 deferoxamine

Status

License statusAuthorised
Licence Issued07/02/1980
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back